Action Intercos - ICOS

Intercos Spa (ICOS) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

12,12

( 0,83% )

Prix Achat

12,00

Prix Vente

12,30

Volume échangé

62 408

12,02 Fourchette du Jour 12,24

10,42 Plage de 52 semaines 14,26

Cap du marché

1,168B

Clôture Veille

12,02

Ouverture

12,02

Dernière Transaction

12.12

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

99 709 €

Actions en circulation

96 364 020

Rendement du Dividende (LTM)

0,2 (1,65%)

Ratio Cours sur Bénéfices

23,22

Bénéfice par action (BPA)

0,51

Chiffre d'affairess (LTM)

1,05B

Bénéfice net (LTM)

49,83M

Intercos S.p.A., together with its subsidiaries, creates, produces, and markets cosmetics and skin care products worldwide. The company operates through Make Up, Skincare, and Hair & Body segments. It offers powders, foundation, lipsticks, mascara, nail polish, delivery systems, creams, serums, derm... Intercos S.p.A., together with its subsidiaries, creates, produces, and markets cosmetics and skin care products worldwide. The company operates through Make Up, Skincare, and Hair & Body segments. It offers powders, foundation, lipsticks, mascara, nail polish, delivery systems, creams, serums, dermo cosmetic lotions, and hair care products. The company sells its products to multinational brands, emerging brands, and retailers. Intercos S.p.A. was founded in 1972 and is headquartered in Agrate Brianza, Italy. Show more

Secteur

Consumer Staples

Industrie

Consumer Products - Household & Personal

Site Web

www.intercos.com

Siège social

Agrate Brianza, Italy

Fondé

1972

Intercos Spa est coté dans le secteur Consumer Staples de la Italian Stock Exchange avec le ticker ICOS. Le dernier cours de clôture d'Intercos était de 12,02 €. Au cours de la dernière année, les actions de Intercos ont été négociées dans une fourchette de prix de 10,42 € à 14,26 €.

Intercos compte actuellement 96 364 020 actions en circulation. La capitalisation boursière d'Intercos est de 1,17 € milliard. Intercos a un ratio cours/bénéfice (ratio PE) de 23.22.

Lilly ICOS LLC Reports Record Sales and Net Income for Second Quarter of 2006

- Worldwide Sales of Cialis Top $233 Million - - Net Income Grows to $75.8 Million for 2006 Second Quarter - BOTHELL, Wash., and INDIANAPOLIS...

Sexual Revolutionaries Mature: Baby Boomers Seek Relationship Satisfaction

New Survey Reveals State of Emotional and Physical Intimacy of Boomer Relationships BOTHELL, Wash. and INDIANAPOLIS, June 22...

Lilly ICOS LLC Reports Results for First Quarter of 2006

- Cialis Attains Leading ED Market Share Position in Eleven Countries - BOTHELL, Wash. and INDIANAPOLIS, Ind., April 20 /PRNewswire-FirstCall/...

Lilly ICOS LLC Reports First Full-Year Profit in its History

- 2005 Fourth Quarter Net Income Surges to $61.4 Million - - 2005 Worldwide Sales Grow 35% - - Company Provides Update on Clinical Plan for BPH...

Lilly ICOS LLC Reports First Quarterly Profit in its History

BOTHELL, Wash. and INDIANAPOLIS, Ind., Oct. 20 /PRNewswire-FirstCall/ -- Lilly ICOS LLC (Lilly ICOS) (NYSE:LLYNYSE:andNYSE:Nasdaq:NYSE:ICOS) is...

Men Make the Grade! B+ for Overall Health Knowledge But Are They Missing the Mark for Sex Education?

-- National Survey Shows Misconceptions Still Prevalent: Nearly One in Three Believe Tight Underwear Can Lead to Erectile Dysfunction NEW YORK...

Lilly ICOS LLC Reports Results for Second Quarter of 2005 - Quarterly net loss narrows to $1.7 million - - Worldwide sales of Ci

Lilly ICOS LLC Reports Results for Second Quarter of 2005 - Quarterly net loss narrows to $1.7 million - - Worldwide sales of Cialis(R), since...

Lilly ICOS Tees Up Plans to Bring Second Year Title Sponsorship of Cialis(R) Western Open to New Level

Lilly ICOS Tees Up Plans to Bring Second Year Title Sponsorship of Cialis(R) Western Open to New Level -- Luke Donald Artwork, Original Vignettes...

Clinical Data Shows Lilly ICOS' Cialis(R) (tadalafil) Improves Erectile Function in ED Patients with Significant, Multiple Comor

Clinical Data Shows Lilly ICOS' Cialis(R) (tadalafil) Improves Erectile Function in ED Patients with Significant, Multiple Comorbid Conditions SAN...

Cialis(R) (tadalafil) Overtakes Viagra to Become Number One Selling Erectile Dysfunction Treatment in France

Cialis(R) (tadalafil) Overtakes Viagra to Become Number One Selling Erectile Dysfunction Treatment in France - Cialis Achieves 49% of Total Tablet...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-0.08	-0.655737704918	12.2	12.56	11.62	68888	12.12422652	DE
4	0.12	1	12	12.66	11.54	78893	12.04495045	DE
12	0.54	4.66321243523	11.58	12.8	11.2	91070	12.12165954	DE
26	0.5	4.30292598967	11.62	13.2	10.58	103901	11.92013744	DE
52	-1.44	-10.6194690265	13.56	14.26	10.42	97121	11.98554775	DE
156	-3.48	-22.3076923077	15.6	16.92	10.42	80944	13.43894756	DE
260	-2.344	-16.2057522124	14.464	17.1	9.755	71573	13.50107357	DE

ICOS - Frequently Asked Questions (FAQ)

What is the current Intercos Spa share price?

The current share price of Intercos Spa is 12,12 €

How many Intercos Spa shares are in issue?

Intercos Spa has 96 364 020 shares in issue

What is the market cap of Intercos Spa?

The market capitalisation of Intercos Spa is EUR 1,17B

What is the 1 year trading range for Intercos Spa share price?

Intercos Spa has traded in the range of 10,42 € to 14,26 € during the past year

What is the PE ratio of Intercos Spa?

The price to earnings ratio of Intercos Spa is 23,22

What is the cash to sales ratio of Intercos Spa?

The cash to sales ratio of Intercos Spa is 1,09

What is the registered address of Intercos Spa?

The registered address for Intercos Spa is Via Guglielmo Marconi 84, Agrate Brianza, Milan, 20864

What is the Intercos Spa website address?

The website address for Intercos Spa is www.intercos.com

Which industry sector does Intercos Spa operate in?

Intercos Spa operates in the Consumer Products - Household & Personal sector

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Intercos Spa (ICOS)

Intercos Spa (ICOS) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de Intercos Spa

ICOS Dernières nouvelles

Lilly ICOS LLC Reports Record Sales and Net Income for Second Quarter of 2006

Sexual Revolutionaries Mature: Baby Boomers Seek Relationship Satisfaction

Lilly ICOS LLC Reports Results for First Quarter of 2006

Lilly ICOS LLC Reports First Full-Year Profit in its History

Lilly ICOS LLC Reports First Quarterly Profit in its History

Men Make the Grade! B+ for Overall Health Knowledge But Are They Missing the Mark for Sex Education?

Lilly ICOS LLC Reports Results for Second Quarter of 2005 - Quarterly net loss narrows to $1.7 million - - Worldwide sales of Ci

Lilly ICOS Tees Up Plans to Bring Second Year Title Sponsorship of Cialis(R) Western Open to New Level

Clinical Data Shows Lilly ICOS' Cialis(R) (tadalafil) Improves Erectile Function in ED Patients with Significant, Multiple Comor

Cialis(R) (tadalafil) Overtakes Viagra to Become Number One Selling Erectile Dysfunction Treatment in France

ICOS - Frequently Asked Questions (FAQ)

ICOS Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Intercos Spa (ICOS)

Intercos Spa (ICOS) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de Intercos Spa

ICOS Dernières nouvelles

Lilly ICOS LLC Reports Record Sales and Net Income for Second Quarter of 2006

Sexual Revolutionaries Mature: Baby Boomers Seek Relationship Satisfaction

Lilly ICOS LLC Reports Results for First Quarter of 2006

Lilly ICOS LLC Reports First Full-Year Profit in its History

Lilly ICOS LLC Reports First Quarterly Profit in its History

Men Make the Grade! B+ for Overall Health Knowledge But Are They Missing the Mark for Sex Education?

Lilly ICOS LLC Reports Results for Second Quarter of 2005 - Quarterly net loss narrows to $1.7 million - - Worldwide sales of Ci

Lilly ICOS Tees Up Plans to Bring Second Year Title Sponsorship of Cialis(R) Western Open to New Level

Clinical Data Shows Lilly ICOS' Cialis(R) (tadalafil) Improves Erectile Function in ED Patients with Significant, Multiple Comor

Cialis(R) (tadalafil) Overtakes Viagra to Become Number One Selling Erectile Dysfunction Treatment in France

ICOS - Frequently Asked Questions (FAQ)

ICOS Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Pourquoi rejoindre ADVFN?

Tout ce dont les traders professionnels ont besoin.

Supprimer les publicités